Lanean...
Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
OBJECTIVES: Osteoporosis is a rapidly rising cause of concern for elderly patients. Various classes of drugs are available in the market. Bisphosphonates are considered as a first-line therapy for the prevention and treatment. Denosumab is an antiresorptive agent which is a RANK ligand inhibitor. Th...
Gorde:
| Argitaratua izan da: | Osteoporos Sarcopenia |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Korean Society of Osteoporosis
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6372735/ https://ncbi.nlm.nih.gov/pubmed/30775470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2016.03.003 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|